Summary of Xiangyu Medical Conference Call Company Overview - **Company**: Xiangyu Medical - **Industry**: Rehabilitation Medical Devices, Brain-Computer Interface (BCI) Key Points and Arguments R&D Investment and Focus - Approximately **60%** of R&D expenses in the first three quarters were allocated to the brain-computer interface (BCI) sector, involving collaboration across **20+** departments to enhance technology and product iterations [2][5] - The company has established a **brain science laboratory** and developed five major technology platforms, leading to the launch of **14** BCI rehabilitation devices, with plans to introduce nearly **30** more products by the upcoming Spring Festival [3][9] Clinical and Market Development - BCI products have been introduced to over **500** top clinical institutions in China, receiving positive feedback [3] - The company is actively pursuing product certification and clinical promotion, collaborating with local health authorities to expedite registration processes [2][6] - The establishment of demonstration wards in collaboration with hospitals is aimed at promoting clinical research and accumulating data [7][8] Commercialization Strategy - The pricing for BCI-related devices ranges from **300,000 to 500,000** yuan, primarily targeting **tertiary hospitals** with substantial research funding [19] - The company aims for a **20%** growth target, leveraging BCI products and expanding into home care and overseas markets to achieve clearer data-driven goals [4][18] Future Revenue Expectations - Current revenue contribution is projected to be less than **10 million yuan** for 2025, with a target to exceed **100 million yuan** in 2026 as more products gain certification and market traction [16][9] - The anticipated revenue from BCI technology is expected to grow significantly, with a sales growth rate potentially exceeding **20% to 30%** over the next **3 to 5 years** [22] Regulatory and Competitive Landscape - The company is compliant with national regulations for BCI product classification, with ongoing efforts to ensure rapid approval of integrated devices [11][20] - Xiangyu Medical has filed over **20** invention patents and **40** utility model patents, establishing a strong competitive barrier in the BCI sector [21] Impact of Healthcare Policies - Current healthcare policies are supportive of the BCI industry, with various regions implementing specific reimbursement policies to facilitate innovation [23] Market Trends and Opportunities - The aging population and increasing demand for rehabilitation services are expected to drive market growth, with a focus on expanding into home care and international markets [17][22] - The company is also exploring the medical robotics market, with plans to introduce more products that integrate BCI technology [24][25] Additional Important Insights - The BCI technology is seen as a transformative force in rehabilitation, potentially replacing traditional methods and expanding the market size significantly [22] - The company emphasizes the importance of data accumulation and algorithm optimization to maintain a leading position in the industry [9][12]